Gábor Sobel - Gynecology

Author Information

Gábor Sobel is currently affiliated with the Department of Obstetrics and Gynecology at Semmelweis University, located at Üllői 78/A, Budapest, 1082, Hungary. His research predominantly focuses on cervical cancer, with specific interests in biomarker discovery, epigenetic silencing, and the role of fibroblasts in cancer progression.

Research Contributions

Gábor Sobel has made significant contributions to the field of gynecology, particularly in the study of cervical cancer. His research has explored various aspects of the disease, including the role of microRNAs, epigenetic modifications, and biomarker identification. Some of his notable works include studies on the epigenetic silencing of TFPI2, the role of miR-20b in cervical intraepithelial neoplasia, and the identification of Claudin-1 as a biomarker for cervical cytology and histology. His work has been instrumental in improving the understanding of cervical cancer progression and the potential for early detection and treatment.

Aliases

G Sobel, Gabor Sobel, Gábor Sobel

Publication and Citation Metrics

Metric	Value
Citation Count	587
h-index	12
Paper Count	29

Publications:

Two ways of epigenetic silencing of TFPI2 in cervical cancer

DOI: 10.1371/journal.pone.0234873

Year: 2020

Increased miR-20b Level in High Grade Cervical Intraepithelial Neoplasia

DOI: 10.1007/s12253-020-00852-w

Year: 2020

Dual-Stained Cervical Cytology and Histology with Claudin-1 and Ki67

DOI: 10.1007/s12253-018-0384-x

Year: 2018

Performance of a new HPV and biomarker assay in the management of hrHPV positive women: Subanalysis of the ongoing multicenter TRACE clinical trial (n > 6,000) to evaluate POU4F3 methylation as a potential biomarker of cervical precancer and cancer

DOI: 10.1002/ijc.30534

Year: 2017

The Value of a Novel Panel of Cervical Cancer Biomarkers for Triage of HPV Positive Patients and for Detecting Disease Progression

DOI: 10.1007/s12253-016-0094-1

Year: 2016

Remodeling of extracellular matrix by normal and tumor-associated fibroblasts promotes cervical cancer progression

DOI: 10.1186/s12885-015-1272-3

Year: 2015

Claudin-1 as a Biomarker of Cervical Cytology and Histology

DOI: 10.1007/s12253-015-9990-z

Year: 2015

Dysregulation of microRNA Expression in Human Cervical Preneoplastic and Neoplastic Lesions

DOI: 10.1007/s12253-014-9871-x

Year: 2014

Claudin 1 Expression Characterizes Human Uterine Cervical Reserve Cells

DOI: 10.1369/0022155413501324

Year: 2013

[Diseases caused by human papillomavirus -- the possibilities and the public health advantages of prevention].

DOI: 10.5546/aap.2013.110

Year: 2012

How Can Gynecologists Identify Abuse?

How should gynecologists manage liver disease in their patients?

Can Smoking and Alcohol Affect Menstrual Cycles?

Who is a Candidate for IUI?

Why are Review Articles Important?

How is it Used?

How Can Nutrition Impact Reproductive Health?

How Can Genetic Conditions Affect Fertility?

What precautions should be taken for women with kidney disease during pregnancy?

What Measures are in Place to Prevent TTIs?

Partnered Content Networks

Relevant Topics